Monthly information related to total number of voting rights and shares composing the share capital - November 30, 2023

Phaxiam Therapeutics S.A.
Phaxiam Therapeutics S.A.


Monthly information related to total number of voting rights and shares composing the share capital _ November 30, 2023

Article 223-16 of general regulation of French Autorité des Marchés Financiers


Listing markets:
Euronext Paris from Euronext (Market segment C - ISIN Code: FR001400K4B1- Symbol: PHXM) &
Nasdaq Global Select Market in the United-States (Symbol: PHXM)
Website : www.phaxiam.com

Date

Total of shares composing the share capital

Total of brut (1) voting rights



Total of net (2) voting rights

January 31, 2023

31 018 553

32 514 771

32 512 271

February 28, 2023

31 018 553

32 516 875

32 514 375

March 31, 2023

31 018 553

32 521 652

32 519 152

April 30, 2023

31 018 553

32 521 642

32 519 142

May 15, 2023

34 120 298

35 623 387

35 620 887

May 31, 2023

34 120 298

35 623 630

35 621 130

June 26, 2023

60 751 054

62 254 388

62 251 888

July 31, 2023

60 751 054

62 254 443

62 251 943

August 31, 2023

60 751 054

62 253 180

62 250 680

September 30, 2023

6 075 105

6 225 265

6 225 016

October 31, 2023

6 075 105

6 225 300

6 225 051

November 30, 2023

6 075 105

6 226 121

6 225 872

(1)   Gross voting rights number (or ? theoretical ? voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
(2)   Without treasury shares.


Attachment